Bipolar Disorder: Symptoms, Diagnosis, and Treatment

Intro

Bipolar disorder is a chronic mood condition in which a person experiences episodes of mania or hypomania — periods of elevated, expansive, or irritable mood with increased energy — alternating with episodes of depression. Between episodes, mood may be relatively stable, though some people experience ongoing symptoms.

Bipolar disorder affects around 1–2% of the population worldwide. It typically emerges in late adolescence or early adulthood and is equally common in men and women, although patterns of episodes may differ. It is one of the most heritable psychiatric conditions and one of the most impairing — but with appropriate treatment and support, most people can manage it effectively.

Key Points

Bipolar disorder is characterised by distinct episodes of mania (or hypomania) and depression, separated by periods of relative stability.
Bipolar I requires at least one manic episode; bipolar II requires at least one hypomanic episode plus depression.
It is highly heritable and is often misdiagnosed as unipolar depression — particularly early in its course.
Mood stabilisers (lithium, valproate, lamotrigine) and certain antipsychotics are the cornerstone of treatment.
Antidepressants without mood stabilisers can trigger manic episodes in people with bipolar disorder.
Suicide risk is substantially elevated — lifetime risk is estimated at 15–20 times higher than the general population.
Regular sleep, structured routines, and avoidance of alcohol and recreational drugs are critical self-management tools.

Background

Bipolar disorder exists on a spectrum. The main recognised subtypes are:

Type	Defining feature
Bipolar I	At least one manic episode (may or may not have depressive episodes)
Bipolar II	At least one hypomanic episode plus at least one major depressive episode; no full mania
Cyclothymia	Persistent instability with hypomanic and depressive symptoms not meeting full criteria; lasting ≥2 years
Bipolar NOS / other	Significant symptoms not fitting neatly into the above

Bipolar II is not a less severe condition. While its manic episodes are less extreme, people with bipolar II often spend more time in depression and may have higher rates of suicidality than those with bipolar I.

Misdiagnosis is common. Studies suggest that around 40% of people with bipolar disorder are first diagnosed with unipolar depression — especially those presenting during depressive phases. The average delay from symptom onset to correct diagnosis is 6–10 years.

Causes or Mechanisms

Bipolar disorder arises from an interplay of genetic, neurobiological, and environmental factors:

Genetics — Heritability is estimated at 60–80%. First-degree relatives of someone with bipolar disorder have a 5–10 times higher risk. Dozens of genetic variants contribute small individual effects; no single gene causes bipolar disorder.

Neurobiological factors — Dysregulation of mood-regulating circuits (prefrontal cortex, amygdala, striatum), disruption of circadian rhythms, and altered neurotransmitter systems (dopamine, serotonin, glutamate) are implicated. Sleep and circadian rhythm disruption is both a trigger and a consequence of episodes.

Environmental triggers — Major life stressors, trauma, substance use, and disrupted sleep-wake schedules can trigger episodes in biologically predisposed individuals. The relationship between stress and bipolar episodes tends to weaken over time as the illness becomes more autonomous (“kindling” model).

Diagnosis

Diagnosis is clinical — based on a thorough history of mood episodes, their pattern, duration, severity, and impact. There is no blood test or scan that confirms bipolar disorder.

Manic episode (DSM-5 / ICD-11)

A distinct period of abnormally elevated, expansive, or irritable mood plus increased goal-directed activity or energy, lasting at least 7 days (or any duration if hospitalisation is required), present for most of the day, nearly every day. Three or more of the following:

Inflated self-esteem or grandiosity
Decreased need for sleep (feeling rested after 3 hours)
More talkative than usual or pressured speech
Racing thoughts (flight of ideas)
Distractibility
Increased goal-directed activity or psychomotor agitation
Excessive involvement in activities with high potential for harm (financial decisions, sexual behaviour, reckless driving)

Hypomanic episode

Same symptom criteria but lasting at least 4 consecutive days, not severe enough to cause marked social or occupational impairment, and not requiring hospitalisation. The change in mood and behaviour is observable by others.

Depressive episode

At least 2 weeks of depressed mood or loss of interest/pleasure most of the day, nearly every day, plus ≥4 additional symptoms (changes in sleep, appetite/weight, energy, concentration, psychomotor activity, or feelings of worthlessness/guilt; suicidal ideation).

Ruling out other causes

Mania or hypomania can be caused by other medical conditions (thyroid disease, neurological conditions, certain medications, substance use). A thorough evaluation includes a medical history, physical examination, and baseline blood tests.

Treatment

Bipolar disorder is a long-term condition requiring sustained management. Acute treatment addresses active episodes; maintenance treatment prevents or reduces future episodes.

Mood stabilisers

Lithium — the most evidence-based maintenance treatment; reduces both manic and depressive episodes and has anti-suicide properties. Requires regular blood level monitoring and kidney/thyroid tests. Narrow therapeutic window.

Valproate (sodium valproate, divalproex) — effective for acute mania and maintenance; widely used; requires monitoring of blood levels and liver function. Contraindicated in pregnancy and in women of childbearing potential unless on effective contraception due to teratogenicity and cognitive effects in children.

Lamotrigine — particularly effective for the depressive phase of bipolar II; less effective for acute mania; mood-stabilising for prevention. Requires slow dose titration to reduce risk of serious skin reactions (Stevens-Johnson syndrome).

Carbamazepine — effective for mania; significant drug interactions; less commonly used.

Antipsychotics

Atypical antipsychotics (quetiapine, aripiprazole, olanzapine, risperidone, lurasidone) are used for:

Acute manic episodes (most are effective)
Acute bipolar depression (quetiapine, lurasidone have evidence)
Maintenance treatment (quetiapine, aripiprazole, olanzapine have evidence)

Quetiapine is one of the most widely prescribed agents across all phases of bipolar disorder.

Antidepressants

Antidepressants (SSRIs, SNRIs) must be used with caution in bipolar disorder. When used without a mood stabiliser or antipsychotic, they can precipitate manic or hypomanic episodes, induce rapid cycling, or worsen the overall course. They are not first-line for bipolar depression. Their use is generally reserved for those with predominant depressive symptoms, used alongside a mood stabiliser, and with close monitoring.

Psychological therapies

Psychotherapy is an important adjunct to medication. Evidence-based approaches include:

Cognitive Behavioural Therapy (CBT) — addresses negative thought patterns, helps identify early warning signs, and supports relapse prevention.
Interpersonal and Social Rhythm Therapy (IPSRT) — focuses on stabilising daily routines and sleep-wake cycles, which strongly influence episode risk.
Family-Focused Therapy (FFT) — involves family members in psychoeducation and communication skills; reduces relapse rates.
Psychoeducation — understanding the condition, recognising prodromal symptoms, and building a relapse prevention plan.

Acute phase management

Acute mania: antipsychotic or mood stabiliser (or combination); safety management; sleep restoration.
Acute bipolar depression: quetiapine or lurasidone; lamotrigine (for prevention); careful consideration of antidepressant addition.
Acute mixed features: mood stabiliser ± antipsychotic; particular care as these are high-risk for suicide.

Risks, Benefits, and Prognosis

Untreated or inadequately treated bipolar disorder carries significant risks:

Suicide — Lifetime risk of completed suicide is estimated at 10–15%, with suicidal ideation much more common. Risk is highest during depressive and mixed episodes.
Substance use disorders — Approximately 60% of people with bipolar I will experience a substance use disorder at some point, most commonly alcohol.
Cognitive impairment — Repeated severe episodes, particularly mania, may be associated with longer-term cognitive changes in memory, attention, and executive function.
Physical health — People with bipolar disorder have elevated rates of metabolic syndrome, obesity, cardiovascular disease, and type 2 diabetes, partly related to medication effects and lifestyle factors.

With effective treatment, many people with bipolar disorder lead full and productive lives. Maintenance medication substantially reduces relapse frequency and severity. Early intervention and psychoeducation improve long-term outcomes. Regular structured routines, sleep hygiene, and avoidance of alcohol and illicit substances are protective.

FAQ

Q: Can bipolar disorder be cured? A: Bipolar disorder is a long-term condition for most people. It can be very effectively managed — many people achieve long periods of stability — but it typically requires ongoing management rather than a fixed course of treatment that ends. Some people experience fewer and milder episodes over time with appropriate treatment; others need sustained medication indefinitely.

Q: Why is sleep so important in bipolar disorder? A: Disrupted sleep — particularly shortened sleep or irregular sleep-wake schedules — is one of the most reliable triggers for manic and hypomanic episodes. The relationship is bidirectional: mania disrupts sleep, and sleep disruption can precipitate mania. Maintaining consistent sleep timing is one of the most practical things a person with bipolar disorder can do to reduce episode risk.

Q: Is it safe to drink alcohol if I have bipolar disorder? A: Alcohol significantly worsens the course of bipolar disorder. It can trigger mood episodes, interfere with the effectiveness of medications (including lithium), worsen depressive symptoms, and increase impulsivity. Most guidelines recommend that people with bipolar disorder avoid or substantially limit alcohol.

Q: Will my children inherit bipolar disorder? A: Bipolar disorder has a significant genetic component. A child with one parent with bipolar disorder has approximately a 10–25% chance of developing the condition. However, most children of people with bipolar disorder do not develop it. Genetic predisposition is not destiny — environmental factors, lifestyle, and early support all play a role.

Q: How long does it take to get the right treatment? A: Finding the right medication or combination often takes time. Mood stabilisers and antipsychotics can take weeks to reach full effect, and adjustments are common. Some people cycle through several medications before finding an effective regimen. Working closely with a psychiatrist and communicating honestly about response and side effects accelerates this process.